This announcement is a separate document:
广东信达律师事务所关于广州安必平医药科技股份有限公司2022年限制性股票激励计划部分限制性股票作废相关事项的法律意见书
Legal Opinion of Guangdong Cinda Law Firm on matters relating to the abolition of some restricted stocks in the 2022 Restricted Stock Incentive Plan of Guangzhou Anbiping Pharmaceutical Technology Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated